Results for the three-month period ended September 30, 2025 (“Q3 2025”) Revenue in Q3 2025 was RMB88.5 million (approx. CAD17.2 million), a decrease of RMB38.4 million (approx. CAD6.8 million), or 30% ...

Fiscal 2025 GAAP diluted net earnings per share ("EPS") of $2.65, down 5.7% from the prior year periodFiscal 2025 non-GAAP ...

CF Energy Corp. (TSX-V: CFY) ("CF Energy" or the "Company", together with its subsidiaries, the "Group"), an energy provider in the People's Republic of China ...

Segment earnings for fiscal 2025 were $507 million, or 21.9 percent of segment net sales. The increase in segment earnings was a result of price realization and higher sales volume, partially offset ...

For the nine months ended September 30, 2025, CureVac recorded revenues of €43.3 million from GSK, €11.1 million from BioNTech, and €1.8 million from CRISPR Therapeutics, compared with €508.3 million, ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

Applying a six-month average interbank exchange rate of ZiG26,84 per US dollar for income-statement conversions, Econet generated US$502 million in inflation-adjusted revenue, representing a 38% ...

NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) ("NIO" or the "Company"), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for ...

Burry has expressed doubts about the sustainability of the AI boom and said November 19 that Nvidia’s stock-based ...

The company is deeply embedded in hospital operations, with a large installed base of equipment and a broad consumables ...

Capitalised words and phrases in this announcement shall, unless the context indicates otherwise, bear the same meanings ascribed thereto in the in the combined offer circular to RFG shareholders date ...

Michael Burry said Nvidia's rebuttal to his critiques contained "one straw man after another," adding that he owns put ...